technetium tc 99m pentetate has been researched along with bms 181321 in 1 studies
| Studies (technetium tc 99m pentetate) | Trials (technetium tc 99m pentetate) | Recent Studies (post-2010) (technetium tc 99m pentetate) | Studies (bms 181321) | Trials (bms 181321) | Recent Studies (post-2010) (bms 181321) |
|---|---|---|---|---|---|
| 3,336 | 275 | 394 | 25 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, CK; Sinusas, AJ; Soufer, R; Zaret, BL | 1 |
1 other study(ies) available for technetium tc 99m pentetate and bms 181321
| Article | Year |
|---|---|
Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
Topics: Animals; Cell Hypoxia; Heart; Male; Myocardial Ischemia; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Perfusion; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Pentetate; Time Factors | 1995 |